CPRX - Catalyst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CPRX is currently covered by 5 analysts with an average price target of $28.65. This is a potential upside of $8.31 (40.86%) from yesterday's end of day stock price of $20.34.

Catalyst Pharmaceuticals's activity chart (see below) currently has 91 price targets and 87 ratings on display. The stock rating distribution of CPRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.14% with an average time for these price targets to be met of 559.33 days.

Highest price target for CPRX is $35, Lowest price target is $30, average price target is $32.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 26-Apr-2016.

Currently out of the existing stock ratings of CPRX, 16 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$35

$14.77 (73.01%)

$35

5 months 23 days ago
(28-Feb-2025)

10/14 (71.43%)

$12.11 (52.91%)

505

Buy

$30

$9.77 (48.29%)

$23

7 months 12 days ago
(08-Jan-2025)

1/2 (50%)

$7.2 (31.58%)

245

Buy

$29

$8.77 (43.35%)

$29

1 years 2 months 14 days ago
(06-Jun-2024)

5/7 (71.43%)

$13.24 (84.01%)

930

Buy

$34

$13.77 (68.07%)

$27

1 years 5 months 19 days ago
(01-Mar-2024)

9/12 (75%)

$16.99 (99.88%)

761

Buy

$24

$6.99 (41.09%)

$22

2 years 2 months 1 days ago
(20-Jun-2023)

5/7 (71.43%)

$11.38 (90.17%)

408

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CPRX (Catalyst Pharmaceuticals) average time for price targets to be met?

On average it took 559.33 days on average for the stock forecasts to be realized with a an average price target met ratio 82.14

Which analyst has the current highest performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the current lower performing score on CPRX (Catalyst Pharmaceuticals) with a proven track record?

JASON GERBERRY

Which analyst has the most public recommendations on CPRX (Catalyst Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 22 price targets and 18 ratings on CPRX

Which analyst is the currently most bullish on CPRX (Catalyst Pharmaceuticals)?

Andrew Fein with highest potential upside - $14.77

Which analyst is the currently most reserved on CPRX (Catalyst Pharmaceuticals)?

Edward Nash with lowest potential downside - -$10.23

Catalyst Pharmaceuticals in the News

Earnings call transcript: Catalyst Pharmaceuticals Q2 2025 beats EPS forecast

Catalyst Pharmaceuticals reported its Q2 2025 earnings, showcasing a significant earnings per share (EPS) beat with actual EPS of $0.68 compared to the forecasted $0.39, representing a 74.36% surprise. The company also surpassed revenue expectations, reporting $146.54 million against a forecast of $140.22 million. With an impressive gross margin of 83.5% and an excellent InvestingPro...

Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run?

Shares of Rigel Pharmaceuticals (RIGL) have been strong performers lately, with the stock up 56.6% over the past month. The stock hit a new 52-week high of $30.43 in the previous session. Rigel has gained 77.2% since the start of the year compared to the -7.6% gain for the Zacks Medical sector and the 5.6%...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?